Address
Email address
Phone number
Uue põlvkonna kuvamisinstrument Odyssey® M 5µm resolutsioon, 18 erinevat kanalit ning >6 log dünaamiline ulatus LI-COR Biotechnology ROHKEM INFOT Uue põlvkonna kuvamisinstrument Odyssey® M 5µm resolutsioon, 18 erinevat kanalit ning >6 log dünaamiline ulatus LI-COR Biotechnology ROHKEM INFOT Uue põlvkonna kuvamisinstrument Odyssey® M ROHKEM INFOT Meie partnerid OÜ Carlova Consult on alates aastast 2000 biotehnoloogia- […]
Name
OSAÜHING CARLOVA CONSULT
Registry code
10667403
VAT number
EE100757431
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
09.08.2000 (24)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
81301 - Landscape service activities 46901 - Non-specialised wholesale trade
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Andres Metspalu 11.03.1951 (73) | 100% - 2 556.00 EUR | Board member | Direct ownership | Founder |
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Geenikliinik OÜ 14851055 | 100% - 2 500.00 EUR | - | - | Founder |
OÜ Hydroduct 11954375 | - | - | - | Founder |
2019 20.07.2020 | 2020 19.07.2021 | 2021 11.07.2022 | 2022 10.07.2023 | |
---|---|---|---|---|
Total Revenue | 423 736 € | 511 657 € | 469 178 € | 326 911 € |
Net profit (loss) for the period | 125 902 € | 3 958 € | -21 748 € | -32 590 € |
Profit Margin | 30% | 1% | -5% | -10% |
Current Assets | 215 942 € | 208 009 € | 168 288 € | 74 596 € |
Fixed Assets | 4 775 € | 7 074 € | 55 803 € | 49 602 € |
Total Assets | 220 717 € | 215 083 € | 224 091 € | 124 198 € |
Current Liabilities | 81 489 € | 101 897 € | 113 644 € | 56 107 € |
Non Current Liabilities | - | - | 29 009 € | 19 243 € |
Total Liabilities | - | - | 142 653 € | 75 350 € |
Share Capital | - | - | - | - |
Equity | 139 228 € | 113 186 € | 81 438 € | 48 848 € |
Employees | 3 | 3 | 3 | 3 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | 142 547.41 € | 23 823.73 € | 7 445.39 € | 2 |
2023 Q4 | 135 725.32 € | 19 316.68 € | 6 220.85 € | 2 |
2023 Q3 | 116 140.04 € | 18 006.26 € | 6 310.77 € | 2 |
2023 Q2 | 148 367.04 € | 21 987.15 € | 6 230.28 € | 2 |
2023 Q1 | 130 862.96 € | 19 685.35 € | 6 372.06 € | 2 |
2022 Q4 | 138 251.51 € | 21 638.81 € | 6 695.88 € | 2 |
2022 Q3 | 113 781.19 € | 18 749.38 € | 6 987.42 € | 2 |
2022 Q2 | 173 172.34 € | 23 439.31 € | 7 036.03 € | 4 |
2022 Q1 | 253 175.92 € | 38 230.85 € | 11 407.89 € | 4 |
2021 Q4 | 183 089.66 € | 21 754.62 € | 8 250.16 € | 4 |
2021 Q3 | 124 185.74 € | 19 231.3 € | 7 959.52 € | 5 |
2021 Q2 | 151 055.17 € | 21 531.51 € | 6 748.5 € | 5 |
2021 Q1 | 336 528.83 € | 40 215.62 € | 8 368.83 € | 4 |
2020 Q4 | 310 097.22 € | 38 771.46 € | 8 322.99 € | 4 |
2020 Q3 | 147 183.54 € | 27 523.43 € | 6 682.48 € | 4 |
2020 Q2 | 208 711.9 € | 24 434.57 € | 7 117.95 € | 4 |
2020 Q1 | 167 747.91 € | 26 943.8 € | 7 517.89 € | 4 |